Time for a Research! Europe

Scientists and scientific institutions in the United States have undergone a quiet revolution during the last 15 years: Whereas politics and advocacy were previously shunned, they are now embraced. Particularly in the medical research arena, but increasingly also in other areas of science, a dense interactive network of organizations, individual contacts, and campaigns exerts influence on public life. Key issues include, naturally, the levels of funding for science, but also the moral and ethica

Written byRichard Gallagher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Scientists and scientific institutions in the United States have undergone a quiet revolution during the last 15 years: Whereas politics and advocacy were previously shunned, they are now embraced. Particularly in the medical research arena, but increasingly also in other areas of science, a dense interactive network of organizations, individual contacts, and campaigns exerts influence on public life. Key issues include, naturally, the levels of funding for science, but also the moral and ethical questions raised by new research, and education and public awareness.

European scientists appear to be lagging in terms of advocacy. For decades they have been hugely frustrated by the European Union's science funding through the Framework Programme (FP). As reported on page 40, researchers were powerless to affect either the scientific priorities or the funding mechanisms, and such was the level of bureaucracy that many top European scientists cold-shouldered the FP altogether.

Perhaps, at last, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies